Literature DB >> 7141560

Chemistry and mutagenicity of alpha-hydroxy nitrosamines.

M Mochizuki, T Anjo, K Takeda, E Suzuki, N Sekiguchi, G F Huang, M Okada.   

Abstract

N-Nitroso-N-(hydroxymethyl)alkylamines, which are key intermediates in the metabolic activation of nitrosamines having a methyl group, were synthesized and their chemical and mutagenic properties were examined. Six N-nitroso-N-(hydroxymethyl)alkylamines (alkyl = methyl, ethyl, n-propyl, n-butyl, sec-butyl, tert-butyl) were prepared by the deoxygenation of N-nitroso-N-(hydroperoxymethyl)alkylamines. Their stability in aqueous solution was highly dependent on pH, being stable in acidic media, but unstable in neutral or alkaline media. The structure also exerted a profound effect on the stability. Thus a branched alkyl group accelerated the decomposition, although compounds with a normal alkyl group showed a similar response to the change of pH. The alkylating activity of the compounds toward deoxyguanosine and thymidine was demonstrated, and was dependent on the reaction solvent used. The overall alkylating activity was found to be highest with the compound ultimately yielding a methylating agent, while a more selective alkylation towards the oxygen, compared to the nitrogen, was observed with the ethylating, propylating and butylating species. Reactions with cysteine and histidine were also observed. A potent mutagenic effect of the N-nitroso-N-(hydroxymethyl)alkylamines was demonstrated in Salmonella typhimurium TA1535 and Escherichia coli WP2 and WP2 hcr-, in the absence of the S9 mix. A good correlation of the activities of the N-nitroso-N-dialkylamines and the N-nitroso-N-(hydroxymethyl)alkylamines with the same alkyl group was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7141560

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


  1 in total

1.  Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.

Authors:  M Mochizuki; M Osabe; T Anjo; E Suzuki; M Okada
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.